Zepbpund Weight Loss - Search News

Ozempic, Weight Loss and Dr. Christopher

Prevention on MSN · 1d

Scientists Explain ‘Ozempic Blindness,’ Link Between Sudden Vision Loss and Weight Loss Drugs

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

Is Ozempic safe for weight loss? What doctors want you to know about blockbuster drug

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 drugs, and whether they're safe.

The New York Times · 12d

How Weight-Loss Drugs Can Upend a Marriage

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of conversations with her husband, Javier. They were in

Rolling Out · 1d

5 hidden dangers of weight loss drugs and vision loss

In the glittering world of celebrity-endorsed weight loss transformations and viral before-and-after photos, a darker narrative is emerging from the shadows

FOX News on MSN · 15h

Weight-loss, diabetes drugs linked to vision problems in small study

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Straight Arrow News on MSN · 1d

Vision loss possibly linked to Ozempic, weight loss injections: Study

Millions of Americans use GLP-1 injections like Ozempic to lose weight. A study is questioning whether they can cause vision loss.

8d

Zepbound sales keep soaring, even as weight loss drug growth slows

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s ...

2don MSN

People taking weight-loss drugs say they are losing their sight. Science is trying to figure out why

There’s no direct link between vision loss and taking the weight loss and diabetes drugs such as Ozempic, Wegovy, Mounjaro, ...

46m

Think Eli Lilly's Stock Is Expensive? Here's Why Selling It Now Could Be a Huge Mistake

The recent surge has been due to the tremendous growth Lilly has achieved due to its highly popular GLP-1 drugs, including ...

10d

Lilly needs a plan to spur weight-loss drug sales, investors say

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

12d

With Zepbound Not Matching Expectations, Should Investors Give Up on Eli Lilly?

Eli Lilly (NYSE: LLY) has underperformed broader equities. While that's not much of an issue in the grand scheme of things, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results